Eubel Brady & Suttman Asset Management Inc Global Blood Therapeutics, Inc. Transaction History

Eubel Brady & Suttman Asset Management Inc

  • $766 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$25.68 - $35.59 $445 Million - $616 Million
17,321,627 New
17,321,627 $600 Million
Q1 2020

May 13, 2020
SELL
$41.72 - $87.2 $1.33 Million - $2.77 Million
-31,796 Closed
0 $0
Q4 2019

Feb 11, 2020
BUY
$45.7 - $81.86 $1.45 Million - $2.6 Million
31,796 New
31,796 $32,000

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Eubel Brady & Suttman Asset Management Inc Portfolio

Follow Eubel Brady & Suttman Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eubel Brady & Suttman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eubel Brady & Suttman Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email